Among the markers expressed in TC, CD5, CD117, and CD205 are uncommonly expressed in primary lung cancers [8], thereby presenting these markers as possible candidates in the IHC panel of thymic tumors when differentiating primary lung cancers. This evidence concerns the gene KIT and lung carcinoma.